Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis Frédéric Becq Leading Article 17 September 2012 Pages: 241 - 259
Rituximab for the Treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia Fredrick Hagemeister Review Article 17 September 2012 Pages: 261 - 272
Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma Frederick LansiganFrancine M. Foss Review Article 17 September 2012 Pages: 273 - 286
Piracetam and Piracetam-Like Drugs Andrei G. MalykhM. Reza Sadaie Review Article 17 September 2012 Pages: 287 - 312
Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Johann D. D. Pitout Review Article 17 September 2012 Pages: 313 - 333
Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity Alexander L. RogovikJean-Pierre ChanoineRan D. Goldman Review Article 17 September 2012 Pages: 335 - 346
Triptorelin Embonate (6-Month Formulation) Gillian M. Keating Adis Drug Profile 17 September 2012 Pages: 347 - 353